Dimitrios Vlachakis is a Professor and Research Director in Genetics as he leads the darkDNA group at the Genetics Laboratory of the Biotechnology Department, School of Applied Biology and Biotechnology of the Agricultural University of Athens and the Translational Precision Medicine group at the URI, Medical School, National & Kapodistrian University of Athens. He is a medical biochemist with postgraduate, doctoral, and postdoctoral studies in the eminent fields of genetics, medicinal chemistry, and drug discovery. He obtained a PhD in Viral Genetics and Antiviral Drug Design from the Welsh School of Pharmacy at Cardiff University. He has also been appointed as an Affiliated Researcher at the Faculty of Natural and Mathematical Sciences at the King’s College London. At the National Organization for Medicines (EOF) he is serving as the Vice President of the Greek HTA (Health Technology Assessment) Committee as well as the Representative of the Greek HTA at the European Commission. Since 2022 he has served as the Editor in Chief of the Journal of Structural Bioinformatics. His research interests include The functional role of long non-coding RNAs; Stress mechanisms and homeostasis via nuclear receptors; and Computational and molecular virology. To date, he has published more than 250 original peer-reviewed articles, 10 ISBN books, 5 scientific patents and has been on the receiving end of numerous grants and awards.
Dimitrios Vlachakis is a Professor and Research Director in Genetics as he leads the darkDNA group at the Genetics Laboratory of the Biotechnology Department, School of Applied Biology and Biotechnology of the Agricultural University of Athens and the Translational Precision Medicine group at the URI, Medical School, National & Kapodistrian University of Athens. He is a medical biochemist with postgraduate, doctoral, and postdoctoral studies in the eminent fields of genetics, medicinal chemistry, and drug discovery. He obtained a PhD in Viral Genetics and Antiviral Drug Design from the Welsh School of Pharmacy at Cardiff University. He has also been appointed as an Affiliated Researcher at the Faculty of Natural and Mathematical Sciences at the King’s College London. At the National Organization for Medicines (EOF) he is serving as the Vice President of the Greek HTA (Health Technology Assessment) Committee as well as the Representative of the Greek HTA at the European Commission. Since 2022 he has served as the Editor in Chief of the Journal of Structural Bioinformatics. His research interests include The functional role of long non-coding RNAs; Stress mechanisms and homeostasis via nuclear receptors; and Computational and molecular virology. To date, he has published more than 250 original peer-reviewed articles, 10 ISBN books, 5 scientific patents and has been on the receiving end of numerous grants and awards.